SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-19-000010
Filing Date
2019-05-22
Accepted
2019-05-22 21:27:16
Documents
1
Period of Report
2019-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155857482059096.html 3  
1 FORM 3 wf-form3_155857482059096.xml 3 4223
  Complete submission text file 0001722024-19-000010.txt   5953
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Issuer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38915 | Film No.: 19847719